The Moroccan Capital Markets Authority (AMMC) has approved the prospectus relating to BMCI’s complete merger of its 100% owned subsidiary, BDSI. The transaction is structured to proceed without a capital increase for BMCI. The approved prospectus (reference VI/EM/013/2025) will be available to the public at BMCI’s headquarters and on its website, and on the AMMC website. An excerpt of the prospectus is expected to be published shortly on BMCI’s website. The merger remains subject to approval by BMCI’s extraordinary general meeting scheduled for 23 June 2025.
Moroccan Capital Markets Authority 2025-05-23
Moroccan Capital Markets Authority approves prospectus for BMCI’s absorption merger of wholly owned subsidiary BDSI
The Moroccan Capital Markets Authority has approved BMCI's prospectus for the merger with its subsidiary BDSI, structured without a capital increase. The prospectus will be accessible at BMCI's headquarters, its website, and the AMMC website. The merger awaits approval from BMCI's extraordinary general meeting on 23 June 2025.